Please assess the completion status of the following clinical trial:

Trial Title: Safety Study of Galantamine in Tic Disorders

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* DSM IV criteria for the diagnosis of Tourette's syndrome, chronic motor or chronic vocal tic disorder~* Accepted method of birth control~Exclusion Criteria:~* Preganancy or nursing~* Unstable medical illness~* Unstable psychiatric illness

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).